Mov Disord Vol 33, Suppl 2 Archives - Page 49 of 177 - MDS Abstracts

2018 International Congress
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
Y. Xiaodong, Q. Yiwei, X. Shaoqing, C. Shengdi, X. Qin (Shanghai, China)
Objective: Emerging evidences suggest that gut microbiota dysbiosis plays a role in Parkinson’s disease (PD). However, the alterations in fecal microbiome in Chinese PD patients…
2018 International Congress
Molecular Genetics and Functional Studies of LRRK2 Gene Variations in Parkinson’s Disease
M-L. Chen, R-M. Wu (Taipei, Taiwan)
Objective: To evaluate the function role of ROC domain in the brains of LRRK2 transgenic mice model and normal control mice. Background: Mutations in leucine-rich…
2018 International Congress
The Association between Infections and Parkinson Disease: A Systematic Review and Meta-analysis
M. Morra, S. Ghozy, E. Sakr, M. Elfaituri, M. Khattab, M. Mahmoud, S. Mehyar, M. Alhattab, A. Ahmed Ismail, M. Abdelmongy, M. Fahmy, E. Gharib, A. Hallab, N. Huy (Cairo, Egypt)
Objective: Our study aimed to recapitulate and summarize the findings from the literature to provide an overview on the correlation between infection and PD. Background:…
2018 International Congress
Deletion of GBA2 in neuronopathic Gaucher’s disease medaka can’t rescue the phenotype
E. Nakanishi, N. Uemura, H. Akiyama, M. Kinoshita, H. Yamakado, S. Takeda, Y. Hirabayashi, R. Takahashi (Kyoto, Japan)
Objective: This study was performed to determine the pathological role of GBA2 in the CNS in GD and GBA1-related PD. Background: Parkinson’s disease (PD) is…
2018 International Congress
Protective effects of Mucuna pruriens seed on rat brain: A therapeutic potential drug for Parkinson’s disease
S. Rajput, S. Sinha (New Delhi, India)
Objective: Objective of present study was evaluate neuroprotective and antiparkinson effects of Mp seed extract on Parkinsons brain of rats. Background: Parkinson’s disease (PD) is…
2018 International Congress
Clinical correlates of stuttering in advanced Parkinson’s disease
T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, M. Hattori, K. Kawabata, K. Hara, D. Nakatsubo, S. Maesawa, Y. Kajita, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)
Objective: We investigated clinical characteristics of a large number of advanced Parkinson’s disease (PD) patients to reveal risk factors for the development of stuttering and…
2018 International Congress
Modulation of CaMKIIa-NR2B interaction in levodopa-induced dyskinesia in 6-OHDA- lesioned Parkinson’s rats
XS. Wang, WW. Wang, CL. Xie (Wenzhou, China)
Objective: In the present study, therefore, we examined the relationship between CaMKII and NR2B in levodopa-induced dyskinesia rats. Background: Long-term treatment with L-dopa leads to…
2018 International Congress
Impaired performance on measures of goal-directed behavior are associated with greater caregiver burden in Parkinson’s disease
N. Dahodwala, C. McMillan, C. Nwadiogbu, J. Liu, A. Miller, M. Pavon, D. Weintraub, L. Massimo (Philadelphia, PA, USA)
Objective: To assess the utility of the Philadelphia Apathy Computerized Task (PACT) in measuring goal-directed behavior in Parkinson’s disease (PD). Background: Impairment in goal-directed behavior…
2018 International Congress
Patient Experience of Parkinson’s Disease Psychosis Management
P. Schmidt, F. Cubillos, A. Diaz, P. Wiener, S. Metz, N. Romero, A. Shim, D. Fredericks (Miami, FL, USA)
Objective: To understand the experience and management of Parkinson’s disease psychosis (PDP). Background: PDP is a troubling non-motor symptom of Parkinson’s disease. Clinical approaches to…
2018 International Congress
Rasch analysis of the Hospital Anxiety and Depression Scale among patients with early-stage Parkinson’s disease
H.J. Yang, B.S. Park, J.Y. Park, E.M. Lee, S.Y. Kim, W.J. Kim, J.H. Kwon (Ulsan, Republic of Korea)
Objective: We aim to assess the psychometric properties of the Korean version of Hospital Anxiety and Depression Scale (HADS) in a sample of early-stage Parkinson's…